TLRY | Tilray BrandsNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$2.65
+$0.10 (+3.92%)

Tilray Brands (TLRY) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat below the 200 on the daily since Feb 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits below the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $2.65 vs 50 $3.70 / 200 $5.40
Projection
No cross projected
Test
No active test
Last cross
Death cross 9 Feb 2026 ยท projected 18 bars out

Weekly as of 30 Oct 16:00 ET

Price
below both $2.53 vs 50 $6.12 / 200 $14.15
Projection
No cross projected
Test
No active test
Last cross
No cross on record

4-hour as of 3 Nov 13:30 ET

Price
below both $2.65 vs 50 $3.17 / 200 $4.11
Projection
No cross projected
Test
No active test
Last cross
Death cross 2 Dec 2025 ยท projected 28 bars out

Cross history

18
crosses on record since 2020
9 golden9 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
9 Feb 2026Death moderatedaily18 bars outNot tested
2 Dec 2025Death4-hour28 bars outNot tested
5 Sep 2025Golden steepdaily18 bars outNot tested
24 Jul 2025Golden4-hour26 bars outโ€”
4 Sep 2024Death4-hour6 bars outโ€”

About TLRY

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$14.6M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.